Collegium Pharmaceutical, Inc.
US ˙ NasdaqGS ˙ US19459J1043

SecurityCOLL / Collegium Pharmaceutical, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership55,512 shares
Latest Disclosed Value $ 1,641,489
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 2.64% increase in ownership of COLL / Collegium Pharmaceutical, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 55,512 shares of Collegium Pharmaceutical, Inc. (US:COLL) valued at $1,641,490 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 54,085 shares of Collegium Pharmaceutical, Inc.. This represents a change in shares of 2.64% during the quarter. The current value of the position is $1,814,687 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Collegium Pharmaceutical EC US19459J1043 55,512 1,427 2.64 1,641 1.67 0.0369
2025-05-28 2025-03-31 NP Collegium Pharmaceutical EC US19459J1043 54,085 0 0.00 1,614 4.20 0.0387
2025-02-25 2024-12-31 NP Collegium Pharmaceutical EC US19459J1043 54,085 -10,418 -16.15 1,550 -37.84 0.0338
2024-11-26 2024-09-30 NP Collegium Pharmaceutical EC US19459J1043 64,503 2,087 3.34 2,492 24.04 0.0471
2024-08-26 2024-06-30 NP Collegium Pharmaceutical EC US19459J1043 62,416 5,115 8.93 2,010 -9.67 0.0409
2024-05-28 2024-03-31 NP Collegium Pharmaceutical EC US19459J1043 57,301 -6,119 -9.65 2,224 13.93 0.0464
2024-02-26 2023-12-31 NP Collegium Pharmaceutical EC US19459J1043 63,420 3,992 6.72 1,952 46.99 0.0417
2023-11-28 2023-09-30 NP Collegium Pharmaceutical EC US19459J1043 59,428 -347 -0.58 1,328 3.43 0.0347
2023-08-25 2023-06-30 NP Collegium Pharmaceutical EC US19459J1043 59,775 6,264 11.71 1,285 0.08 0.0305
2023-05-26 2023-03-31 NP Collegium Pharmaceutical EC US19459J1043 53,511 0 0.00 1,284 3.38 0.0342
2023-02-24 2022-12-31 NP Collegium Pharmaceutical EC US19459J1043 53,511 -5,491 -9.31 1,241 31.32 0.0342
2022-11-25 2022-09-30 NP Collegium Pharmaceutical EC US19459J1043 59,002 6,521 12.43 945 1.72 0.0271
2022-08-25 2022-06-30 NP Collegium Pharmaceutical EC US19459J1043 52,481 -2,415 -4.40 930 -16.83 0.0257
2022-05-26 2022-03-31 NP Collegium Pharmaceutical EC US19459J1043 54,896 2,836 5.45 1,118 14.92 0.0260
2022-02-25 2021-12-31 NP Collegium Pharmaceutical EC US19459J1043 52,060 0 0.00 972 -5.36 0.0211
2021-11-24 2021-09-30 NP Collegium Pharmaceutical EC US19459J1043 52,060 0 0.00 1,028 -16.50 0.0226
2021-08-26 2021-06-30 NP Collegium Pharmaceutical EC US19459J1043 52,060 0 0.00 1,231 -0.24 0.0264
2021-05-27 2021-03-31 NP Collegium Pharmaceutical EC US19459J1043 52,060 0 0.00 1,234 18.33 0.0280
2021-02-25 2020-12-31 NP Collegium Pharmaceutical EC US19459J1043 52,060 -6,043 -10.40 1,043 -13.81 0.0267
2020-11-25 2020-09-30 NP Collegium Pharmaceutical EC US19459J1043 58,103 0 0.00 1,210 19.00 0.0388
2020-08-27 2020-06-30 NP Collegium Pharmaceutical EC US19459J1043 58,103 6,163 11.87 1,017 19.81 0.0332
2020-06-01 2020-03-31 NP Collegium Pharmaceutical EC US19459J1043 51,940 2,059 4.13 848 -17.35 0.0347
2020-02-27 2019-12-31 NP Collegium Pharmaceutical EC 19459J104 49,881 1,268 2.61 1,027 83.87 0.0309
2019-11-27 2019-09-30 NP Collegium Pharmaceutical EC US19459J1043 48,613 48,613 558 0.0184
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.